The Journal of Pathology

Cover image for Vol. 234 Issue 4

Edited By: C Simon Herrington, Editor-in-Chief

Impact Factor: 7.33

ISI Journal Citation Reports © Ranking: 2013: 3/76 (Pathology); 15/203 (Oncology)

Online ISSN: 1096-9896

Associated Title(s): The Journal of Pathology: Clinical Research

Editorial Board

Professor C Simon Herrington
Division of Cancer Research, Medical Research Institute, Jacqui Wood Cancer Centre, University of Dundee, James Arrott Drive, Ninewells Hospital And Medical School, Dundee, DD1 9SY

HerringtonPhoto_resized.jpgSimon Herrington graduated in biochemistry from the University of Cambridge in 1982 and medicine from the University of London in 1985. He trained in Internal Medicine (MRCP 1988) and then became a CRC clinical research fellow in the Nuffield Department of Pathology, University of Oxford, receiving his DPhil in 1991. He was then appointed clinical lecturer in pathology in Oxford where he completed his training in clinical cellular pathology, gaining the MRCPath in 1994. He was appointed clinical senior lecturer and consultant in pathology at the University of Liverpool in 1995 and was promoted to a personal chair in 1999. In 2003, he was appointed to the chair of Pathology at the University of St Andrews, moving to the Chair of Pathology at the University of Dundee in 2010. He also works as a consultant pathologist, specialising in gynaecological pathology. He is a member of the Cancer Research UK science funding committee, sits on the Board of the Association for International Cancer Research and is Past-President of the International Society of Gynecological Pathologists. He has been on the Editorial Board of the Journal of Pathology since 1995, serving as Editor-in-Chief from 2002-2008.

EDITOR Emeritus
Professor Peter A Hall

Peter Hall qualified from St Bartholomew’s Hospital Medical School in 1982 and trained in histopathology at the London Hospital. After completing MD and PhD research at St Bartholomew’s Hospital Department of Medical Oncology and the ICRF Laboratories in London, he became Senior Lecturer in Pathology at the RPMS. He has held Professorial appointments in the Universities of London, Dundee and was the Musgrave Professor of Pathology at Queen’s University Belfast. Until recently he was Chairman of the Department of Molecular Oncology and also Senior Consultant & Adviser to the CEO at the King Faisal Specialist Hospital & Research Centre in Riyadh. He was also Professor of Molecular Pathology at the Alfaisal University College of Medicine.

He is now an Adjunct Principal Scientist at KFSH&RC. His interests lie in molecular pathology and understanding the pathobiology of disease. He is the author of more than 230 research publications and was in 2006 awarded the Pathological Society’s Goudie Medal for seminal contributions to pathological research. Before becoming Editor-in-Chief of the Journal of Pathology in 2008, he had been Editor of Haematological Oncology and Associate Editor of the Journal of Pathology.


Professor David T Bonthron
Molecular Medicine Unit, University of Leeds, St. James's University Hospital, Leeds, LS9 7TF, UK

David BonthronDavid Bonthron is Centenary Professor of Molecular Medicine at the University of Leeds. He obtained his BA in Biochemistry from the University of Cambridge in 1980, and clinical degrees from Oxford in 1983. After a research fellowship with Stuart Orkin at Harvard Medical School (1985-88), he returned to the U.K. to specialize in paediatrics and clinical genetics. In 1988 he took up a Senior Lecturer post at the University of Edinburgh, where in 1998 he was appointed to a personal chair in Medical Genetics. He moved to Leeds in 1999 and was Head of the University’s former Molecular Medicine Unit. His research activity spans the interface between clinical and molecular genetics, with particular interests in rare recessive phenotypes and in genomic imprinting. He is a former member of the MRC Molecular and Cellular Medicine Board, and has been Associate Editor of the Journal of Medical Genetics since 2009.

Dr Philip J Coates
Division of Pathology and Neuroscience, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK

Phillip CoatesPhilip Coates obtained his BSc in Biochemistry at UMIST, Manchester in 1981 and worked in the diagnostic histopathology laboratory at St Bartholomew’s Hospital, London from 1982 to 1985. He studied for a PhD in Biochemistry and Medicine at St Bartholomew’s from 1985 to 1988 under the supervision of Prof Israel Doniach, investigating human pituitary gland physiology and the pathogenesis of pituitary adenomas. He subsequently worked at St Thomas’s Hospital, London, Ninewells Hospital and Medical School, Dundee and The Medical Research Radiobiology Unit in Oxford before returning to Dundee in 1999. He has over 100 research publications in fields that include endocrine pathology, molecular biology techniques applied to pathology, studies of viruses in human cancer, control of cell proliferation, survival and apoptosis, and the role of p53 and p53-family members in these processes. His current research investigates the mechanisms of radiation-induced damage and carcinogenesis and he has been a member of the committee of the Association for Radiation Research since 2005. He joined the Editorial Board of the Journal of Pathology in 2002 and became an Associate Editor of the Journal in 2008.

Dr Eric S White
University of Michigan Medical School and Graduate Program in Biomedical Sciences, Division of Pulmonary and Critical Care Medicine, 1150 W. Medical Center Drive, 6301 MSRB III SPC 5642, Ann Arbor, MI 48109-5642, USA

  Eric WhiteEric S. White, MD, is Associate Professor of Medicine at the University of Michigan Medical School. Dr. White received his medical degree magna cum laude from the State University of New York Health Science Center at Brooklyn, and completed both Internal Medicine Residency and Pulmonary and Critical Care Fellowship at the University of Michigan. His research laboratory focuses primarily on the role of the extracellular matrix in lung fibrogenesis, at the molecular level and as prognostic and therapeutic targets. Dr. White’s lab is also interested in the intracellular pathways that mediate extracellular matrix signals with an emphasis on the tumor suppressor PTEN. In addition to these responsibilities, Dr. White specializes in the care and management of patients with sarcoidosis, pulmonary fibrosis, and other interstitial lung diseases. Dr. White has authored or co-authored over 50 peer-reviewed research manuscripts and has served on the Editorial Boards of The Journal of Pathology (since 2008) and the American Journal of Respiratory and Critical Care Medicine (since 2009).


Professor Ming-Qing Du
Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK

Ming-Qing DuDr Du is a Professor of Oncological Pathology and Consultant Molecular Pathologist, currently leading an active lymphoma research group and the molecular diagnostic haematopathology service at the Addenbrooke’s Hospital, University of Cambridge. He obtained his MB from Hebei Medical College, PR China in 1984, and subsequently PhD from King’s College Hospital School of Medicine and Dentistry, University of London in 1990. After a three-year postdoctoral fellowship with Professor David Phillips at the Institute of Cancer Research, Sutton, UK, he joined Professor Peter G. Isaacson’s research laboratory at Department of Histopathology, University College London in 1993. In August 2003, he joined the Department of Pathology, University of Cambridge and has been working there since then. His main research interests are molecular genetics of lymphoma and their applications in disease diagnosis and prognosis.

Professor David Huntsman
Department of Pathology and Laboratory Medicine, University of British Columbia, BCCA, Pathology, 600 West 10th, Vancouver, Canada

David HuntsmanDr. David Huntsman is a Professor in the Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology at The University of British Columbia (UBC) and is the Dr. Chew Wei Memorial Professor of Gynaelcologic Oncology. He is a a Staff Pathologist at the BC Cancer Agency (BCCA), and a Consulting Pathologist at the Vancouver General Hospital (VGH). Dr. Huntsman is currently the Director of the BC multidisciplinary ovarian cancer research team (OvCaRe), Medical Director of the Centre for Translational and Applied Genomics (CTAG) at the BCCA, and co-Director of the Genetic Pathology Evaluation Centre (GPEC) at the Jack Bell Research Centre, VGH. Dr. Huntsman's research has led to development of predictive and prognostic tissue based cancer biomarkers for ovarian cancer and a wide variety of other tumour types. His team created a blueprint for subtype specific ovarian cancer control and have been leaders in the application of novel genomics technologies to ovarian cancer. As collaboration is critical in his field, Dr. Huntsman happily leads and engages in a wide number of multidisciplinary research groups. Most recently he has been working on the creation of broad based personalized medicine initiative for British Columbia.

Dr Hartmut Koeppen
Staff Pathologist, Genentech, South San Francisco, CA 94080, USA

Hartmut KoeppenHartmut Koeppen, a native of Bremen, Germany, received an MD degree from the Albert-Ludwigs Universität in Freiburg and a PhD from The University of Chicago where Hans Schreiber supervised his work on mechanisms of tumor immune escape. Also at the University of Chicago Hartmut completed a combined residency in anatomical and clinical pathology and a fellowship in Hematopathology under the mentorship of James Vardiman. For the last 12 years Hartmut has been in the Department of Pathology at Genentech with a brief interruption to pursue clinical interests in hematopathology and molecular diagnostics at the MD Anderson Cancer Center in Houston. Hartmut’s research interests at Genentech have focused on the pathogenesis of colon cancer as well as identifying predictive markers for success of antiangiogenic therapies. In addition to his own research Hartmut has supported and led programs to identify and develop new therapies for oncology indications. He has contributed to over 50 peer-reviewed research papers and has been an Associate Editor for the Journal of Pathology since late 2009.

Professor Jorge Reis-Filho
Department of Pathology, Memorial Sloan-Kettering Cancer Centre, 1275 York Avenue, New York, NY 10065, USA

Professor Reis-Filho completed an Anatomical Pathology residency at the Federal University of Parana, Brazil in 2001. Following a Surgical and Molecular Pathology Fellowship at the Institute of Molecular Pathology and Immunology, University of Porto, Portugal, Professor Reis-Filho moved to the Institute of Cancer Research in 2002 to undertake a clinical research fellowship in the Breakthrough Breast Cancer Research Centre. Under the supervision of Professor Alan Ashworth and Professor Sunil Lakhani at the ICR, Professor Fernando Schmitt at the University of Minho, Portugal, Professor Reis-Filho completed his PhD in 2006. He was subsequently appointed team leader of the Molecular Pathology team in the Breakthrough Breast Cancer Research Centre in 2006, and in 2010 was appointed Professor of Molecular Pathology at the Institute of Cancer Research. Professor Reis-Filho has made a major contribution to the molecular characterisation of breast cancer subtypes. His research has led to characterisation of the pathological features and prognostic implications of basal-like and triple-negative breast carcinomas, and has described the genetic features of special histological types of breast cancer. Professor Reis-Filho also has contributed to the development and characterisation of conditional mouse models for specific subgroups of breast cancers and BRAF-driven melanomas.

Professor Natalie Wong
Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin NT, Hong Kong, China

  Natalie WongNathalie Wong is currently Professor at the Dept. of Anatomical and Cellular Pathology, Chinese University of Hong Kong, where she is also a principal investigator of the State Key Laboratory in Oncology in South China. She received her DPhil in Clinical Biochemistry from University of Oxford and post-doctoral training at King’s College School of Medicine and Density, London, before returning to Hong Kong in 1993. Her primary research focuses on understanding the carcinogenetic events during the stepwise development of hepatocellular carcinoma, and the molecular pathogenesis of hepatocellular carcinoma associated with differing etiologies. Other interests include genome analysis for oncogenic somatic variants, tumor biology, signaling transduction and cancer-related microRNAs. She has been a member of editorial board of Journal of Pathology since 2011 and is presently also academic editor of PLoS One.


Professor K Aldape
Houston, Texas
Professor M Alison
London, UK
Dr MJ Arends
Cambridge, UK
Professor A Ashworth
London, UK
Dr J Aster
Boston, USA
Dr D Bell
Washington DC, USA
Professor D Berman
Kingston, Canada 
Professor FT Bosman
Lausanne, Switzerland
Professor D Bowtell
Melbourne, Australia
Professor AD Burt
Adelaide, Australia
Dr C Chelala
London, UK
Dr A Chinnaiyan
Ann Arbor, USA
Dr N Coleman
Cambridge, UK
Professor C Cuvelier
Ghent, Belgium
Professor MJAP Daemen
Maastricht, The Netherlands
Professor AP Dei Tos
Treviso, Italy
Dr DC Douek
Bethesda, USA
Professor I Ellis
Nottingham, UK
Professor A Flanagan
London, UK
Professor CDM Fletcher
Boston, USA
Professor W Foulkes
Montreal, Canada
Professor AJ Freemont
Manchester, UK
Professor C Gregory
Edinburgh, UK
Professor S Hamilton
Houston, USA
Professor AM Hanby
Leeds, UK
Professor N Harris
Boston, USA
Professor A Hartmann
Erlangen, Germany
Professor KJ Hillan
San Francisco, USA
Professor PCW Hoogendoorn
Leiden, The Netherlands
Professor M Ilyas
Nottingham, UK
Professor LJ Jones
London, UK
Professor J Jonkers
Amsterdam, The Netherlands
Dr A Jubb
San Francisco, USA
Dr G Kelly
London, UK
Dr E Korsching
Muenster, Germany
Professor T Krausz
Chicago, USA
Dr K Kurian
Bristol, UK
Dr M Ladanyi
New York, USA
Professor SR Lakhani
Brisbane, Australia
Professor N Lemoine
London, UK
Dr John Le Quesne
Cambridge, UK
Professor D Lo
Hong Kong, China
Professor G Lozano
Houston, USA
Professor Y Lu
Beijing, China
Professor JE Martin
London, UK
Professor CJLM Meijer
Amsterdam, The Netherlands
Professor E Meinl
München, Germany
Professor le Ming Shih
Baltimore, USA
Professor G Murray
Aberdeen, UK
Dr P Murray
Birmingham, UK
Professor G Neidobitek
Berlin, Germany
Dr S Ogino
Boston, USA
Dr J Oosting
Leiden, The Netherlands
Dr Y Osamura
Tokai, Japan
Professor MG Papotti
Turin, Italy
Dr M Sanchez-Cespedes
Barcelona, Spain
Professor DK Shibata
Los Angeles, USA
Professor M Sobrinho-Simoes
Porto, Portugal
Professor I Stamenkovic
Lausanne, Switzerland
Dr C Swanton
London, UK
Professor W Timens
Groningen, The Netherlands
Professor IPM Tomlinson
London, UK
Professor M Van de Rijn
Stanford, USA
Professor H Van Krieken
Nijmegen, The Netherlands
Professor P Waring
Melbourne, Australia
Dr B Weigelt
New York, USA
Professor NA Wright
London, UK